Integra LifeSciences acquires Rebound Therapeutics — 4 things to know

Integra LifeSciences announced the acquisition of Rebound Therapeutics Sept. 9, adding the company’s minimally invasive neurosurgery system.

Advertisement

Four things to know:

1. The neurosurgery platform features integrated optics and illumination, enabling interfacing with OR monitors.

2. The technology expands Integra’s neurosurgical and therapeutic-focused portfolio.

3. Integra doesn’t anticipate the acquisition to have a material financial impact this year.

4. Financial terms of the deal were not disclosed.

More articles on devices:
‘A dream come true’: Dr. Jorge Chahla strives for success at Rush
New York hospital invests $2M in imaging system for spine, brain — 4 things to know
What Stryker’s spine division stands to gain from 5 acquisitions 

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.